Single-cell analysis of megakaryopoiesis in peripheral CD34+ cells: insights into ETV6-related thrombocytopenia

祖细胞 造血 癌症研究 细胞生物学 分子生物学 生物 干细胞
作者
Timothée Bigot,Elisa Gabinaud,Laurent Hannouche,Véronique Sbarra,Elisa Andersen,Delphine Bastelica,Céline Falaise,Denis Bernot,Manal Ibrahim‐Kosta,Morange Pierre-Emmanuel,Marie Loosveld,Paul Saultier,Dominique Payet-Bornet,Marie‐Christine Alessi,Delphine Potier,Marjorie Poggi
出处
期刊:Journal of Thrombosis and Haemostasis [Wiley]
卷期号:21 (9): 2528-2544 被引量:1
标识
DOI:10.1016/j.jtha.2023.04.007
摘要

Background Germline mutations in the ETV6 transcription factor gene are responsible for familial thrombocytopenia and leukemia predisposition syndrome. Although previous studies have shown that ETV6 plays an important role in megakaryocyte (MK) maturation and platelet formation, the mechanisms by which ETV6 dysfunction promotes thrombocytopenia remain unclear. Objectives To decipher the transcriptional mechanisms and gene regulatory network linking ETV6 germline mutations and thrombocytopenia. Methods Presuming that ETV6 mutations result in selective effects at a particular cell stage, we applied single-cell RNA sequencing to understand gene expression changes during megakaryopoiesis in peripheral CD34+ cells from healthy controls and patients with ETV6-related thrombocytopenia. Results Analysis of gene expression and regulon activity revealed distinct clusters partitioned into 7 major cell stages: hematopoietic stem/progenitor cells, common-myeloid progenitors (CMPs), MK-primed CMPs, granulocyte-monocyte progenitors, MK-erythroid progenitors (MEPs), progenitor MKs/mature MKs, and platelet-like particles. We observed a differentiation trajectory in which MEPs developed directly from hematopoietic stem/progenitor cells and bypassed the CMP stage. ETV6 deficiency led to the development of aberrant cells as early as the MEP stage, which intensified at the progenitor MK/mature MK stage, with a highly deregulated core “ribosome biogenesis” pathway. Indeed, increased translation levels have been documented in patient CD34+-derived MKs with overexpression of ribosomal protein S6 and phosphorylated ribosomal protein S6 in both CD34+-derived MKs and platelets. Treatment of patient MKs with the ribosomal biogenesis inhibitor CX-5461 resulted in an increase in platelet-like particles. Conclusion These findings provide novel insight into both megakaryopoiesis and the link among ETV6, translation, and platelet production.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
fransiccarey发布了新的文献求助10
3秒前
研友_ngqb28发布了新的文献求助10
7秒前
7秒前
9秒前
zhuzhu007完成签到 ,获得积分10
10秒前
mei发布了新的文献求助10
12秒前
13秒前
dengfeng发布了新的文献求助10
14秒前
17秒前
yuze_22完成签到,获得积分10
18秒前
科里斯皮尔应助simey采纳,获得10
19秒前
19秒前
20秒前
111发布了新的文献求助10
21秒前
wangjingli666应助kjhr采纳,获得30
21秒前
wanci应助gypsophila采纳,获得10
22秒前
学术小白完成签到,获得积分10
22秒前
陈啦啦发布了新的文献求助10
24秒前
谦让戎完成签到,获得积分10
25秒前
欣慰听南发布了新的文献求助10
25秒前
李爱国应助海边的卡夫卡采纳,获得10
28秒前
31秒前
Mm完成签到,获得积分10
32秒前
38秒前
上官若男应助zxy采纳,获得10
40秒前
asdfghjkl完成签到,获得积分10
43秒前
wanci应助典雅的俊驰采纳,获得10
43秒前
45秒前
叶子完成签到,获得积分10
45秒前
田嘉杰发布了新的文献求助10
46秒前
Lin发布了新的文献求助20
47秒前
48秒前
zxy完成签到,获得积分20
48秒前
51秒前
材料人完成签到,获得积分10
52秒前
52秒前
53秒前
所所应助Lee采纳,获得10
57秒前
zxy发布了新的文献求助10
58秒前
希望天下0贩的0应助huang采纳,获得10
58秒前
高分求助中
Un calendrier babylonien des travaux, des signes et des mois: Séries iqqur îpuš 1036
IG Farbenindustrie AG and Imperial Chemical Industries Limited strategies for growth and survival 1925-1953 800
Sustainable Land Management: Strategies to Cope with the Marginalisation of Agriculture 600
Prochinois Et Maoïsmes En France (et Dans Les Espaces Francophones) 500
重庆市新能源汽车产业大数据招商指南(两链两图两池两库两平台两清单两报告) 400
Division and square root. Digit-recurrence algorithms and implementations 400
Offline version of the Proceedings of 15th EWTEC 2023, Bilbao 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2534308
求助须知:如何正确求助?哪些是违规求助? 2171333
关于积分的说明 5579897
捐赠科研通 1891592
什么是DOI,文献DOI怎么找? 942716
版权声明 565075
科研通“疑难数据库(出版商)”最低求助积分说明 502437